Aaron S.

Project Management | Research & Development | Biotechnology | Pharmaceuticals

United States of America
EN

Aaron is a proven biologics leader adept at managing teams to discover and develop novel first-in-class antibody therapeutics. Prior to Twist Bioscience, he served as Chief Scientific Officer of LakeP...see more

  • Biotechnology & Life Sciences
  • Pharmaceutical

400

/hr
  • Pre-vetted expert
  • Confirmed hourly rate
  • Available on short notice

Experience

Chief Scientific Officer

Twist Bioscience
2 years
Current position
Sep 2020 - Present
Building a robust antibody discovery engine, leveraging our core competency in DNA synthesis and synthetic library generation, for antibody lead discovery and optimization. Providing e...see more

Chief Scientific Officer, Biopharma & VP, Protein Engineering

Twist Bioscience
2 years
May 2018 - Sep 2020
Building a robust antibody discovery engine, leveraging our core competency in DNA synthesis and synthetic library generation, for antibody lead discovery and optimization. Providing e...see more

Chief Scientific Officer

LakePharma, Inc.
1 year
Dec 2016 - May 2018
Head of the LakePharma Antibody Center (50+ Scientists) focused on the discovery and development of therapeutic antibodies from both hybridoma and phage display platforms. The Antibody...see more

Vice President of Protein Sciences

Surrozen
7 months
May 2016 - Dec 2016
Surrozen is a newly launched biopharmaceutical company founded by world-leading scientists from Stanford University, Drs. Chris Garcia, Roel Nusse, and Calvin Kuo. The company is focuse...see more

Vice President of Research

Sutro Biopharma, Inc.
4 years
Jun 2012 - May 2016
Oversee all research functions (Antibody/Protein Engineering, Protein Biochemistry, Informatics, Chemistry) – 30+ Scientists Utilized Sutro's proprietary cell free protein synthesis tec...see more

Senior Director of Antibody Engineering

OncoMed Pharmaceuticals
6 years
Jun 2006 - Jun 2012
Responsible for all human antibody lead discovery, engineering, and technology development Discovered tarextumab (Anti-Notch2/3, OMP-59R5, Phase 2), vantictumab (Anti-Fzd7, OMP-18R5, Ph...see more

Senior Director of Lead Discovery

Dyax
7 years
Apr 1999 - Jun 2006
Directed Lead Discovery team of 20+ Scientists (Selection/Screening and Molecular Biology): Selection/Screening: Use of antibody/peptide/protein phage display libraries to find therapeu...see more

Industries, roles and expertise

Industry experience

  • Biotechnology & Life Sciences
  • Pharmaceutical

Expertise

  • Project Management
  • Research & Development
  • Discovery